A Review of the Diagnosis and Management of Premalignant Pancreatic Cystic Lesions

Margaret G Keane, Elham Afghani, Margaret G Keane, Elham Afghani

Abstract

Pancreatic cystic lesions are an increasingly common clinical finding. They represent a heterogeneous group of lesions that include two of the three known precursors of pancreatic cancer, intraductal papillary mucinous neoplasms (IPMN) and mucinous cystic neoplasms (MCN). Given that approximately 8% of pancreatic cancers arise from these lesions, careful surveillance and timely surgery offers an opportunity for early curative resection in a disease with a dismal prognosis. This review summarizes the current evidence and guidelines for the diagnosis and management of IPMN/MCN. Current pre-operative diagnostic tests in pancreatic cysts are imperfect and a proportion of patients continue to undergo unnecessary surgical resection annually. Balancing cancer prevention while preventing surgical overtreatment, continues to be challenging when managing pancreatic cysts. Cyst fluid molecular markers, such as KRAS, GNAS, VHL, PIK3CA, SMAD4 and TP53, as well as emerging endoscopic technologies such as needle-based confocal laser endomicroscopy and through the needle microbiopsy forceps demonstrate improved diagnostic accuracy. Differences in management and areas of uncertainty between the guidelines are also discussed, including indications for surgery, surveillance protocols and if and when surveillance can be discontinued.

Keywords: computer tomography; diagnosis; endoscopic ultrasonography; intraductal papillary mucinous neoplasm; magnetic resonance imaging; management; mucinous cystic neoplasm; pancreatic cancer; pancreatic cystic lesions; surveillance.

Conflict of interest statement

The authors have no conflict of interest.

References

    1. Arnold M., Abnet C.C., Neale R.E., Vignat J., Giovannucci E.L., McGlynn K.A., Bray F. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 2020;159:335–349.e315. doi: 10.1053/j.gastro.2020.02.068.
    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. Ca A Cancer J. Clin. 2020;70:7–30. doi: 10.3322/caac.21590.
    1. Huang J., Lok V., Ngai C.H., Zhang L., Yuan J., Lao X.Q., Ng K., Chong C., Zheng Z.J., Wong M.C.S. Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer. Gastroenterology. 2021;160:744–754. doi: 10.1053/j.gastro.2020.10.007.
    1. Lippi G., Mattiuzzi C. The global burden of pancreatic cancer. Arch. Med Sci. AMS. 2020;16:820–824. doi: 10.5114/aoms.2020.94845.
    1. Rahib L., Smith B.D., Aizenberg R., Rosenzweig A.B., Fleshman J.M., Matrisian L.M. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–2921. doi: 10.1158/0008-5472.CAN-14-0155.
    1. Arnold M., Rutherford M.J., Bardot A., Ferlay J., Andersson T.M., Myklebust T.A., Tervonen H., Thursfield V., Ransom D., Shack L., et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): A population-based study. Lancet Oncol. 2019;20:1493–1505. doi: 10.1016/S1470-2045(19)30456-5.
    1. Pereira S.P., Oldfield L., Ney A., Hart P.A., Keane M.G., Pandol S.J., Li D., Greenhalf W., Jeon C.Y., Koay E.J., et al. Early detection of pancreatic cancer. Lancet Gastroenterol. Hepatol. 2020;5:698–710. doi: 10.1016/S2468-1253(19)30416-9.
    1. Kanno A., Masamune A., Hanada K., Maguchi H., Shimizu Y., Ueki T., Hasebe O., Ohtsuka T., Nakamura M., Takenaka M., et al. Multicenter study of early pancreatic cancer in Japan. Pancreatology. 2018;18:61–67. doi: 10.1016/j.pan.2017.11.007.
    1. Neoptolemos J.P., Kleeff J., Michl P., Costello E., Greenhalf W., Palmer D.H. Therapeutic developments in pancreatic cancer: Current and future perspectives. Nat. Rev. Gastroenterol. Hepatol. 2018;15:333–348. doi: 10.1038/s41575-018-0005-x.
    1. Kamisawa T., Wood L.D., Itoi T., Takaori K. Pancreatic cancer. Lancet. 2016;388:73–85. doi: 10.1016/S0140-6736(16)00141-0.
    1. Kenner B.J., Chari S.T., Cleeter D.F., Go V.L. Early detection of sporadic pancreatic cancer: Strategic map for innovation--a white paper. Pancreas. 2015;44:686–692. doi: 10.1097/MPA.0000000000000369.
    1. Laffan T.A., Horton K.M., Klein A.P., Berlanstein B., Siegelman S.S., Kawamoto S., Johnson P.T., Fishman E.K., Hruban R.H. Prevalence of unsuspected pancreatic cysts on MDCT. Ajr. Am. J. Roentgenol. 2008;191:802–807. doi: 10.2214/AJR.07.3340.
    1. Spinelli K.S., Fromwiller T.E., Daniel R.A., Kiely J.M., Nakeeb A., Komorowski R.A., Wilson S.D., Pitt H.A. Cystic pancreatic neoplasms: Observe or operate. Ann. Surg. 2004;239:651–657; discussion 657–659. doi: 10.1097/01.sla.0000124299.57430.ce.
    1. Lee K.S., Sekhar A., Rofsky N.M., Pedrosa I. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am. J. Gastroenterol. 2010;105:2079–2084. doi: 10.1038/ajg.2010.122.
    1. De Jong K., Nio C.Y., Mearadji B., Phoa S.S., Engelbrecht M.R., Dijkgraaf M.G., Bruno M.J., Fockens P. Disappointing interobserver agreement among radiologists for a classifying diagnosis of pancreatic cysts using magnetic resonance imaging. Pancreas. 2012;41:278–282. doi: 10.1097/MPA.0b013e31822899b6.
    1. Bosman F.T., Carneiro F., Hruban R.H., Theise N.D. In: WHO Classification of Tumours of the Digestive System. 4th ed. Bosman F.T., Carneiro F., Hruban R.H., Theise N.D., editors. WHO; Paris, France: 2010.
    1. Kromrey M.L., Bulow R., Hubner J., Paperlein C., Lerch M.M., Ittermann T., Volzke H., Mayerle J., Kuhn J.P. Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut. 2018;67:138–145. doi: 10.1136/gutjnl-2016-313127.
    1. Malleo G., Marchegiani G., Borin A., Capelli P., Accordini F., Butturini G., Pederzoli P., Bassi C., Salvia R. Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm. Ann. Surg. 2015;261:984–990. doi: 10.1097/SLA.0000000000000884.
    1. Kwong W.T., Hunt G.C., Fehmi S.M., Honerkamp-Smith G., Xu R., Lawson R.D., Tang R.S., Gonzalez I., Krinsky M.L., Giap A., et al. Low Rates of Malignancy and Mortality in Asymptomatic Patients With Suspected Neoplastic Pancreatic Cysts Beyond 5 Years of Surveillance. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 2016;14:865–871. doi: 10.1016/j.cgh.2015.11.013.
    1. Munigala S., Gelrud A., Agarwal B. Risk of pancreatic cancer in patients with pancreatic cyst. Gastrointest. Endosc. 2016;84:81–86. doi: 10.1016/j.gie.2015.10.030.
    1. Del Chiaro M., Ateeb Z., Hansson M.R., Rangelova E., Segersvard R., Kartalis N., Ansorge C., Lohr M.J., Arnelo U., Verbeke C. Survival Analysis and Risk for Progression of Intraductal Papillary Mucinous Neoplasia of the Pancreas (IPMN) Under Surveillance: A Single-Institution Experience. Ann. Surg. Oncol. 2017;24:1120–1126. doi: 10.1245/s10434-016-5661-x.
    1. Pergolini I., Sahora K., Ferrone C.R., Morales-Oyarvide V., Wolpin B.M., Mucci L.A., Brugge W.R., Mino-Kenudson M., Patino M., Sahani D.V., et al. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center. Gastroenterology. 2017;153:1284–1294.e1. doi: 10.1053/j.gastro.2017.07.019.
    1. Nara S., Onaya H., Hiraoka N., Shimada K., Sano T., Sakamoto Y., Esaki M., Kosuge T. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: Clinical, radiological, and pathological analysis of 123 cases. Pancreas. 2009;38:8–16. doi: 10.1097/MPA.0b013e318181b90d.
    1. Hwang D.W., Jang J.Y., Lee S.E., Lim C.S., Lee K.U., Kim S.W. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: A 15-year experience at a single academic institution. Langenbeck’s Arch. Surg. Dtsch. Ges. Fur Chir. 2012;397:93–102. doi: 10.1007/s00423-010-0674-6.
    1. Kim S.C., Park K.T., Lee Y.J., Lee S.S., Seo D.W., Lee S.K., Kim M.H., Jang S.J., Byun J.H., Han D.J. Intraductal papillary mucinous neoplasm of the pancreas: Clinical characteristics and treatment outcomes of 118 consecutive patients from a single center. J. Hepato-Biliary-Pancreat. Surg. 2008;15:183–188. doi: 10.1007/s00534-007-1231-8.
    1. Nagai K., Doi R., Kida A., Kami K., Kawaguchi Y., Ito T., Sakurai T., Uemoto S. Intraductal papillary mucinous neoplasms of the pancreas: Clinicopathologic characteristics and long-term follow-up after resection. World J. Surg. 2008;32:271–278; discussion 279–280. doi: 10.1007/s00268-007-9281-2.
    1. Tanaka M., Fernandez-del Castillo C., Adsay V., Chari S., Falconi M., Jang J.Y., Kimura W., Levy P., Pitman M.B., Schmidt C.M., et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–197. doi: 10.1016/j.pan.2012.04.004.
    1. Le H., Ziogas A., Rhee J.M., Lee J.G., Lipkin S.M., Zell J.A. A population-based, descriptive analysis of malignant intraductal papillary mucinous neoplasms of the pancreas. Cancer Epidemiol. Biomark. Prev. 2008;17:2737–2741. doi: 10.1158/1055-9965.EPI-08-0417.
    1. Nilsson L.N., Keane M.G., Shamali A., Millastre Bocos J., Marijinissen van Zanten M., Antila A., Verdejo Gil C., Del Chiaro M., Laukkarinen J. Nature and management of pancreatic mucinous cystic neoplasm (MCN): A systematic review of the literature. Pancreatology. 2016;16:1028–1036. doi: 10.1016/j.pan.2016.09.011.
    1. Tanaka M., Fernandez-Del Castillo C., Kamisawa T., Jang J.Y., Levy P., Ohtsuka T., Salvia R., Shimizu Y., Tada M., Wolfgang C.L. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17:738–753. doi: 10.1016/j.pan.2017.07.007.
    1. van Huijgevoort N.C.M., Del Chiaro M., Wolfgang C.L., van Hooft J.E., Besselink M.G. Diagnosis and management of pancreatic cystic neoplasms: Current evidence and guidelines. Nat. Rev. Gastroenterol. Hepatol. 2019;16:676–689. doi: 10.1038/s41575-019-0195-x.
    1. Jais B., Rebours V., Malleo G., Salvia R., Fontana M., Maggino L., Bassi C., Manfredi R., Moran R., Lennon A.M., et al. Serous cystic neoplasm of the pancreas: A multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) Gut. 2016;65:305–312. doi: 10.1136/gutjnl-2015-309638.
    1. Furukawa T., Klöppel G., Volkan Adsay N., Albores-Saavedra J., Fukushima N., Horii A., Hruban R.H., Kato Y., Klimstra D.S., Longnecker D.S., et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: A consensus study. Virchows Arch. Int. J. Pathol. 2005;447:794–799. doi: 10.1007/s00428-005-0039-7.
    1. Mino-Kenudson M., Fernández-del Castillo C., Baba Y., Valsangkar N.P., Liss A.S., Hsu M., Correa-Gallego C., Ingkakul T., Perez Johnston R., Turner B.G., et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut. 2011;60:1712–1720. doi: 10.1136/gut.2010.232272.
    1. Furukawa T. Subtyping of IPMN. In: Su G.H., editor. Pancreatic Cancer: Methods and Protocols. Springer; New York, NY, USA: 2019. pp. 1–8.
    1. Hamilton S.R., Aaltonen L.A. WHO Classification of Tumours of the Digestive System. WHO; Lyon, France: 2000.
    1. Nilsson L., Antila A., Millastre Bocos J., Marijinissen Van Zanten M., Shamali A., Verdejo Gil C., Keane M.G., Laukkarinen J., Del Chiaro M. The current management of mucinous cystic neoplasms (MCN) of the pancreas. Pancreas. 2015;15:S113. doi: 10.1016/j.pan.2015.05.400.
    1. Wu B.U., Sampath K., Berberian C.E., Kwok K.K., Lim B.S., Kao K.T., Giap A.Q., Kosco A.E., Akmal Y.M., Difronzo A.L., et al. Prediction of malignancy in cystic neoplasms of the pancreas: A population-based cohort study. Am. J. Gastroenterol. 2014;109:121–129. doi: 10.1038/ajg.2013.334. quiz 130.
    1. Oyama H., Tada M., Takagi K., Tateishi K., Hamada T., Nakai Y., Hakuta R., Ijichi H., Ishigaki K., Kanai S., et al. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms. Gastroenterology. 2020;158:226–237.e225. doi: 10.1053/j.gastro.2019.08.032.
    1. Yamaguchi K., Ohuchida J., Ohtsuka T., Nakano K., Tanaka M. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology. 2002;2:484–490. doi: 10.1159/000064716.
    1. Aronsson L., Bengtsson A., Torén W., Andersson R., Ansari D. Intraductal papillary mucinous carcinoma versus pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Int. J. Surg. 2019;71:91–99. doi: 10.1016/j.ijsu.2019.09.014.
    1. Wu J., Jiao Y., Dal Molin M., Maitra A., de Wilde R.F., Wood L.D., Eshleman J.R., Goggins M.G., Wolfgang C.L., Canto M.I., et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc. Natl. Acad. Sci. USA. 2011;108:21188–21193. doi: 10.1073/pnas.1118046108.
    1. Wu J., Matthaei H., Maitra A., Dal Molin M., Wood L.D., Eshleman J.R., Goggins M., Canto M.I., Schulick R.D., Edil B.H., et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci. Transl. Med. 2011;3:92ra66. doi: 10.1126/scitranslmed.3002543.
    1. Furukawa T., Kuboki Y., Tanji E., Yoshida S., Hatori T., Yamamoto M., Shibata N., Shimizu K., Kamatani N., Shiratori K. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci. Rep. 2011;1:161. doi: 10.1038/srep00161.
    1. Cibulskis K., Lawrence M.S., Carter S.L., Sivachenko A., Jaffe D., Sougnez C., Gabriel S., Meyerson M., Lander E.S., Getz G. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 2013;31:213–219. doi: 10.1038/nbt.2514.
    1. Fischer C.G., Wood L.D. From somatic mutation to early detection: Insights from molecular characterization of pancreatic cancer precursor lesions. J. Pathol. 2018;246:395–404. doi: 10.1002/path.5154.
    1. Amato E., Molin M.D., Mafficini A., Yu J., Malleo G., Rusev B., Fassan M., Antonello D., Sadakari Y., Castelli P., et al. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J. Pathol. 2014;233:217–227. doi: 10.1002/path.4344.
    1. Fischer C.G., Beleva Guthrie V., Braxton A.M., Zheng L., Wang P., Song Q., Griffin J.F., Chianchiano P.E., Hosoda W., Niknafs N., et al. Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations. Gastroenterology. 2019;157:1123–1137.e1122. doi: 10.1053/j.gastro.2019.06.001.
    1. Omori Y., Ono Y., Tanino M., Karasaki H., Yamaguchi H., Furukawa T., Enomoto K., Ueda J., Sumi A., Katayama J., et al. Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features. Gastroenterology. 2019;156:647–661.e642. doi: 10.1053/j.gastro.2018.10.029.
    1. Basturk O., Hong S.M., Wood L.D., Adsay N.V., Albores-Saavedra J., Biankin A.V., Brosens L.A., Fukushima N., Goggins M., Hruban R.H., et al. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am. J. Surg. Pathol. 2015;39:1730–1741. doi: 10.1097/PAS.0000000000000533.
    1. Conner J.R., Mariño-Enríquez A., Mino-Kenudson M., Garcia E., Pitman M.B., Sholl L.M., Srivastava A., Doyle L.A. Genomic Characterization of Low- and High-Grade Pancreatic Mucinous Cystic Neoplasms Reveals Recurrent KRAS Alterations in "High-Risk" Lesions. Pancreas. 2017;46:665–671. doi: 10.1097/MPA.0000000000000805.
    1. Singhi A.D., Nikiforova M.N., Fasanella K.E., McGrath K.M., Pai R.K., Ohori N.P., Bartholow T.L., Brand R.E., Chennat J.S., Lu X., et al. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2014;20:4381–4389. doi: 10.1158/1078-0432.CCR-14-0513.
    1. Iacobuzio-Donahue C.A., Wilentz R.E., Argani P., Yeo C.J., Cameron J.L., Kern S.E., Hruban R.H. Dpc4 protein in mucinous cystic neoplasms of the pancreas: Frequent loss of expression in invasive carcinomas suggests a role in genetic progression. Am. J. Surg. Pathol. 2000;24:1544–1548. doi: 10.1097/00000478-200011000-00011.
    1. Peters M.L.B., Eckel A., Mueller P.P., Tramontano A.C., Weaver D.T., Lietz A., Hur C., Kong C.Y., Pandharipande P.V. Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: Results of a simulation model. Pancreatology. 2018;18:928–934. doi: 10.1016/j.pan.2018.07.009.
    1. Choi S.H., Park S.H., Kim K.W., Lee J.Y., Lee S.S. Progression of Unresected Intraductal Papillary Mucinous Neoplasms of the Pancreas to Cancer: A Systematic Review and Meta-analysis. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 2017;15:1509–1520.e1504. doi: 10.1016/j.cgh.2017.03.020.
    1. Noë M., Niknafs N., Fischer C.G., Hackeng W.M., Beleva Guthrie V., Hosoda W., Debeljak M., Papp E., Adleff V., White J.R., et al. Genomic characterization of malignant progression in neoplastic pancreatic cysts. Nat. Commun. 2020;11:4085. doi: 10.1038/s41467-020-17917-8.
    1. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67:789–804. doi: 10.1136/gutjnl-2018-316027.
    1. Vege S.S., Ziring B., Jain R., Moayyedi P. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:819–822. doi: 10.1053/j.gastro.2015.01.015. quize 812–813.
    1. Elta G.H., Enestvedt B.K., Sauer B.G., Lennon A.M. ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts. Am. J. Gastroenterol. 2018;113:464–479. doi: 10.1038/ajg.2018.14.
    1. Megibow A.J., Baker M.E., Morgan D.E., Kamel I.R., Sahani D.V., Newman E., Brugge W.R., Berland L.L., Pandharipande P.V. Management of Incidental Pancreatic Cysts: A White Paper of the ACR Incidental Findings Committee. J. Am. Coll. Radiol. 2017;14:911–923. doi: 10.1016/j.jacr.2017.03.010.
    1. Sugiyama M., Atomi Y. Intraductal papillary mucinous tumors of the pancreas: Imaging studies and treatment strategies. Ann. Surg. 1998;228:685–691. doi: 10.1097/00000658-199811000-00008.
    1. Fernandez-del Castillo C., Targarona J., Thayer S.P., Rattner D.W., Brugge W.R., Warshaw A.L. Incidental pancreatic cysts: Clinicopathologic characteristics and comparison with symptomatic patients. Arch. Surg. 2003;138:427–434. doi: 10.1001/archsurg.138.4.427.
    1. Crippa S., Salvia R., Warshaw A.L., Dominguez I., Bassi C., Falconi M., Thayer S.P., Zamboni G., Lauwers G.Y., Mino-Kenudson M., et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: Lessons from 163 resected patients. Ann. Surg. 2008;247:571–579. doi: 10.1097/SLA.0b013e31811f4449.
    1. Testini M., Gurrado A., Lissidini G., Venezia P., Greco L., Piccinni G. Management of mucinous cystic neoplasms of the pancreas. World J. Gastroenterol. 2010;16:5682–5692. doi: 10.3748/wjg.v16.i45.5682.
    1. Pergolini I., Schorn S., Jäger C., Göß R., Novotny A., Friess H., Ceyhan G.O., Demir I.E. Diabetes mellitus in intraductal papillary mucinous neoplasms: A systematic review and meta-analysis. Surgery. 2021;169:411–418. doi: 10.1016/j.surg.2020.07.006.
    1. Schweber A.B., Brooks C., Agarunov E., Sethi A., Poneros J.M., Schrope B.A., Kluger M.D., Chabot J.A., Gonda T.A. New onset diabetes predicts progression of low risk pancreatic mucinous cysts. Pancreatology. 2020;20:1755–1763. doi: 10.1016/j.pan.2020.09.015.
    1. Jang J.W., Kim M.H., Jeong S.U., Kim J., Park D.H., Lee S.S., Seo D.W., Lee S.K., Kim J.H. Clinical characteristics of intraductal papillary mucinous neoplasm manifesting as acute pancreatitis or acute recurrent pancreatitis. J. Gastroenterol. Hepatol. 2013;28:731–738. doi: 10.1111/jgh.12121.
    1. Morales-Oyarvide V., Mino-Kenudson M., Ferrone C.R., Gonzalez-Gonzalez L.A., Warshaw A.L., Lillemoe K.D., Fernández-del Castillo C. Acute pancreatitis in intraductal papillary mucinous neoplasms: A common predictor of malignant intestinal subtype. Surgery. 2015;158:1219–1225. doi: 10.1016/j.surg.2015.04.029.
    1. Bassi C., Salvia R., Gumbs A.A., Butturini G., Falconi M., Pederzoli P. The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3. Langenbeck’s Arch. Surg. Dtsch. Ges. Fur Chir. 2002;387:281–285. doi: 10.1007/s00423-002-0324-8.
    1. Safi F., Schlosser W., Falkenreck S., Beger H.G. Prognostic value of CA 19-9 serum course in pancreatic cancer. Hepatogastroenterology. 1998;45:253–259.
    1. Wang W., Zhang L., Chen L., Wei J., Sun Q., Xie Q., Zhou X., Zhou D., Huang P., Yang Q., et al. Serum carcinoembryonic antigen and carbohydrate antigen 19-9 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: A meta-analysis. Biomed. Rep. 2015;3:43–50. doi: 10.3892/br.2014.376.
    1. Kim J.R., Jang J.Y., Kang M.J., Park T., Lee S.Y., Jung W., Chang J., Shin Y., Han Y., Kim S.W. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas. J. Hepato-Biliary-Pancreat. Sci. 2015;22:699–707. doi: 10.1002/jhbp.275.
    1. Fritz S., Hackert T., Hinz U., Hartwig W., Büchler M.W., Werner J. Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas. Br. J. Surg. 2011;98:104–110. doi: 10.1002/bjs.7280.
    1. Scarà S., Bottoni P., Scatena R. CA 19-9: Biochemical and Clinical Aspects. Adv. Exp. Med. Biol. 2015;867:247–260. doi: 10.1007/978-94-017-7215-0_15.
    1. Gemenetzis G., Bagante F., Griffin J.F., Rezaee N., Javed A.A., Manos L.L., Lennon A.M., Wood L.D., Hruban R.H., Zheng L., et al. Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann. Surg. 2017;266:339–345. doi: 10.1097/SLA.0000000000001988.
    1. Meng Q., Shi S., Liang C., Liang D., Xu W., Ji S., Zhang B., Ni Q., Xu J., Yu X. Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: A systematic review and meta-analysis. Onco Targets. 2017;10:4591–4598. doi: 10.2147/OTT.S145708.
    1. Gaiser R.A., Pessia A., Ateeb Z., Davanian H., Fernández Moro C., Alkharaan H., Healy K., Ghazi S., Arnelo U., Valente R., et al. Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer. Sci. Rep. 2019;9:10208. doi: 10.1038/s41598-019-46634-6.
    1. Overbeek K.A., Alblas M., Gausman V., Kandel P., Schweber A.B., Brooks C., Van Riet P.A., Wallace M.B., Gonda T.A., Cahen D.L., et al. Development of a stratification tool to identify pancreatic intraductal papillary mucinous neoplasms at lowest risk of progression. Aliment. Pharmacol. Ther. 2019;50:789–799. doi: 10.1111/apt.15440.
    1. Marchegiani G., Andrianello S., Borin A., Dal Borgo C., Perri G., Pollini T., Romanò G., D’Onofrio M., Gabbrielli A., Scarpa A., et al. Systematic review, meta-analysis, and a high-volume center experience supporting the new role of mural nodules proposed by the updated 2017 international guidelines on IPMN of the pancreas. Surgery. 2018;163:1272–1279. doi: 10.1016/j.surg.2018.01.009.
    1. Del Chiaro M., Beckman R., Ateeb Z., Orsini N., Rezaee N., Manos L., Valente R., Yuan C., Ding D., Margonis G.A., et al. Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann. Surg. 2020;272:1118–1124. doi: 10.1097/SLA.0000000000003174.
    1. Amini N., Rezaee N., Habib J.R., Blair A., Beckman R.M., Manos L., Cameron J.L., Hruban R.H., Weiss M.J., Fishman E.K., et al. Minimal main pancreatic duct dilatation in small branch duct intraductal papillary mucinous neoplasms associated with high-grade dysplasia or invasive carcinoma. Hpb. 2020 doi: 10.1016/j.hpb.2020.08.004.
    1. Kwon W., Han Y., Byun Y., Kang J.S., Choi Y.J., Kim H., Jang J.Y. Predictive Features of Malignancy in Branch Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Meta-Analysis. Cancers. 2020;12:2618. doi: 10.3390/cancers12092618.
    1. Han S., Raijman I., Machicado J.D., Edmundowicz S.A., Shah R.J. Per Oral Pancreatoscopy Identification of Main-duct Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Duct Stones: Not Mutually Exclusive. Pancreas. 2019;48:792–794. doi: 10.1097/MPA.0000000000001333.
    1. Postlewait L.M., Ethun C.G., McInnis M.R., Merchant N., Parikh A., Idrees K., Isom C.A., Hawkins W., Fields R.C., Strand M., et al. Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study. JAMA Surg. 2017;152:19–25. doi: 10.1001/jamasurg.2016.3598.
    1. Serafini S., Sperti C., Brazzale A.R., Cecchin D., Zucchetta P., Pierobon E.S., Ponzoni A., Valmasoni M., Moletta L. The Role of Positron Emission Tomography in Clinical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas. Cancers. 2020;12:807. doi: 10.3390/cancers12040807.
    1. Liu H., Cui Y., Shao J., Shao Z., Su F., Li Y. The diagnostic role of CT, MRI/MRCP, PET/CT, EUS and DWI in the differentiation of benign and malignant IPMN: A meta-analysis. Clin. Imaging. 2020;72:183–193. doi: 10.1016/j.clinimag.2020.11.018.
    1. Bick B.L., Enders F.T., Levy M.J., Zhang L., Henry M.R., Abu Dayyeh B.K., Chari S.T., Clain J.E., Farnell M.B., Gleeson F.C., et al. The string sign for diagnosis of mucinous pancreatic cysts. Endoscopy. 2015;47:626–631. doi: 10.1055/s-0034-1391484.
    1. Brugge W.R., Lewandrowski K., Lee-Lewandrowski E., Centeno B.A., Szydlo T., Regan S., del Castillo C.F., Warshaw A.L. Diagnosis of pancreatic cystic neoplasms: A report of the cooperative pancreatic cyst study. Gastroenterology. 2004;126:1330–1336. doi: 10.1053/j.gastro.2004.02.013.
    1. de Jong K., van Hooft J.E., Nio C.Y., Gouma D.J., Dijkgraaf M.G., Bruno M.J., Fockens P. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scand. J. Gastroenterol. 2012;47:1056–1063. doi: 10.3109/00365521.2012.674970.
    1. Thornton G.D., McPhail M.J., Nayagam S., Hewitt M.J., Vlavianos P., Monahan K.J. Endoscopic ultrasound guided fine needle aspiration for the diagnosis of pancreatic cystic neoplasms: A meta-analysis. Pancreatology. 2013;13:48–57. doi: 10.1016/j.pan.2012.11.313.
    1. De Jong K., Poley J.W., van Hooft J.E., Visser M., Bruno M.J., Fockens P. Endoscopic ultrasound-guided fine-needle aspiration of pancreatic cystic lesions provides inadequate material for cytology and laboratory analysis: Initial results from a prospective study. Endoscopy. 2011;43:585–590. doi: 10.1055/s-0030-1256440.
    1. Barresi L., Tarantino I., Traina M., Granata A., Curcio G., Azzopardi N., Baccarini P., Liotta R., Fornelli A., Maimone A., et al. Endoscopic ultrasound-guided fine needle aspiration and biopsy using a 22-gauge needle with side fenestration in pancreatic cystic lesions. Dig. Liver Dis. 2014;46:45–50. doi: 10.1016/j.dld.2013.06.008.
    1. Park W.G., Mascarenhas R., Palaez-Luna M., Smyrk T.C., O’Kane D., Clain J.E., Levy M.J., Pearson R.K., Petersen B.T., Topazian M.D., et al. Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts. Pancreas. 2011;40:42–45. doi: 10.1097/MPA.0b013e3181f69f36.
    1. Faias S., Cravo M.M., Chaves P., Pereira L. A comparative analysis of glucose and carcinoembryonic antigen in diagnosis of pancreatic mucinous cysts: A systematic review and meta-analysis. Gastrointest. Endosc. 2021 doi: 10.1016/j.gie.2021.01.021.
    1. Ngamruengphong S., Lennon A.M. Analysis of Pancreatic Cyst Fluid. Surg. Pathol. Clin. 2016;9:677–684. doi: 10.1016/j.path.2016.05.010.
    1. Springer S., Wang Y., Dal Molin M., Masica D.L., Jiao Y., Kinde I., Blackford A., Raman S.P., Wolfgang C.L., Tomita T., et al. A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts. Gastroenterology. 2015;149:1501–1510. doi: 10.1053/j.gastro.2015.07.041.
    1. Singhi A.D., McGrath K., Brand R.E., Khalid A., Zeh H.J., Chennat J.S., Fasanella K.E., Papachristou G.I., Slivka A., Bartlett D.L., et al. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia. Gut. 2018;67:2131–2141. doi: 10.1136/gutjnl-2016-313586.
    1. Springer S., Masica D.L., Dal Molin M., Douville C., Thoburn C.J., Afsari B., Li L., Cohen J.D., Thompson E., Allen P.J., et al. A multimodality test to guide the management of patients with a pancreatic cyst. Sci. Transl. Med. 2019;11 doi: 10.1126/scitranslmed.aav4772.
    1. Wittmann J., Kocjan G., Sgouros S.N., Deheragoda M., Pereira S.P. Endoscopic ultrasound-guided tissue sampling by combined fine needle aspiration and trucut needle biopsy: A prospective study. Cytopathol. Off. J. Br. Soc. Clin. Cytol. 2006;17:27–33. doi: 10.1111/j.1365-2303.2006.00313.x.
    1. Del Chiaro M., Segersvard R., Pozzi Mucelli R., Rangelova E., Kartalis N., Ansorge C., Arnelo U., Blomberg J., Lohr M., Verbeke C. Comparison of preoperative conference-based diagnosis with histology of cystic tumors of the pancreas. Ann. Surg. Oncol. 2014;21:1539–1544. doi: 10.1245/s10434-013-3465-9.
    1. Li Y., Jin H., Liao D., Qian B., Zhang Y., Xu M., Han S. Contrast-enhanced harmonic endoscopic ultrasonography for the differential diagnosis of pancreatic masses: A systematic review and meta-analysis. Mol. Clin. Oncol. 2019;11:425–433. doi: 10.3892/mco.2019.1908.
    1. Giovannini M., Caillol F., Lemaistre A., Monges G., Napoleon B., Pujol B. Endoscopic ultrasound guided confocal microscopy: Atlas of cystic pancreatic lesions. Endosc. Ultrasound. 2014;3:S19–S21. doi: 10.4103/2303-9027.129481.
    1. Napoleon B., Lemaistre A.I., Pujol B., Caillol F., Lucidarme D., Bourdariat R., Morellon-Mialhe B., Fumex F., Lefort C., Lepilliez V., et al. A novel approach to the diagnosis of pancreatic serous cystadenoma: Needle-based confocal laser endomicroscopy. Endoscopy. 2015;47:26–32. doi: 10.1055/s-0034-1390693.
    1. Nakai Y., Iwashita T., Park do H., Samarasena J.B., Lee J.G., Chang K.J. Diagnosis of pancreatic cysts: EUS-guided, through-the-needle confocal laser-induced endomicroscopy and cystoscopy trial: DETECT study. Gastrointest. Endosc. 2015;81:1204–1214. doi: 10.1016/j.gie.2014.10.025.
    1. Kamboj A.K., Dewitt J.M., Modi R.M., Conwell D.L., Krishna S.G. Confocal Endomicroscopy Characteristics of Different Intraductal Papillary Mucinous Neoplasm Subtypes. Jop J. Pancreas. 2017;18:198–202.
    1. Napoleon B., Palazzo M., Lemaistre A.I., Caillol F., Palazzo L., Aubert A., Buscail L., Maire F., Morellon B.M., Pujol B., et al. Needle-based confocal laser endomicroscopy of pancreatic cystic lesions: A prospective multicenter validation study in patients with definite diagnosis. Endoscopy. 2019;51:825–835. doi: 10.1055/a-0732-5356.
    1. Keane M.G., Wehnert N., Perez-Machado M., Fusai G.K., Thorburn D., Oppong K.W., Carroll N., Metz A.J., Pereira S.P. A prospective trial of CONfocal endomicroscopy in CYSTic lesions of the pancreas: CONCYST-01. Endosc. Int. Open. 2019;7:E1117–E1122. doi: 10.1055/a-0957-2976.
    1. Krishna S.G., Brugge W.R., Dewitt J.M., Kongkam P., Napoleon B., Robles-Medranda C., Tan D., El-Dika S., McCarthy S., Walker J., et al. Needle-based confocal laser endomicroscopy for the diagnosis of pancreatic cystic lesions: An international external interobserver and intraobserver study (with videos) Gastrointest. Endosc. 2017;86:644–654.e642. doi: 10.1016/j.gie.2017.03.002.
    1. Krishna S.G., Hart P.A., Malli A., Kruger A.J., McCarthy S.T., El-Dika S., Walker J.P., Dillhoff M.E., Manilchuk A., Schmidt C.R., et al. Endoscopic Ultrasound-Guided Confocal Laser Endomicroscopy Increases Accuracy of Differentiation of Pancreatic Cystic Lesions. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 2020;18:432–440.e436. doi: 10.1016/j.cgh.2019.06.010.
    1. Yang D., Trindade A.J., Yachimski P., Benias P., Nieto J., Manvar A., Ho S., Esnakula A., Gamboa A., Sethi A., et al. Histologic Analysis of Endoscopic Ultrasound-Guided Through the Needle Microforceps Biopsies Accurately Identifies Mucinous Pancreas Cysts. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 2019;17:1587–1596. doi: 10.1016/j.cgh.2018.11.027.
    1. Tacelli M., Celsa C., Magro B., Barchiesi M., Barresi L., Capurso G., Arcidiacono P.G., Cammà C., Crinò S.F. Diagnostic performance of endoscopic ultrasound through-the-needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta-analysis. Dig. Endosc. Off. J. Jpn. Gastroenterol. Endosc. Soc. 2020;32:1018–1030. doi: 10.1111/den.13626.
    1. Cheesman A.R., Zhu H., Liao X., Szporn A.H., Kumta N.A., Nagula S., DiMaio C.J. Impact of EUS-guided microforceps biopsy sampling and needle-based confocal laser endomicroscopy on the diagnostic yield and clinical management of pancreatic cystic lesions. Gastrointest. Endosc. 2019;91:1095–1104. doi: 10.1016/j.gie.2019.12.022.
    1. Kurita Y., Kuwahara T., Hara K., Mizuno N., Okuno N., Matsumoto S., Obata M., Koda H., Tajika M., Shimizu Y., et al. Diagnostic ability of artificial intelligence using deep learning analysis of cyst fluid in differentiating malignant from benign pancreatic cystic lesions. Sci. Rep. 2019;9:6893. doi: 10.1038/s41598-019-43314-3.
    1. Machicado J.D., Chao W.L., Carlyn D.E., Pan T.Y., Poland S., Alexander V.L., Maloof T.G., Dubay K., Ueltschi O., Middendorf D.M., et al. High performance in risk stratification of intraductal papillary mucinous neoplasms by confocal laser endomicroscopy image analysis with convolutional neural networks (with video) Gastrointest. Endosc. 2021 doi: 10.1016/j.gie.2020.12.054.
    1. Khashab M.A., Shin E.J., Amateau S., Canto M.I., Hruban R.H., Fishman E.K., Cameron J.L., Edil B.H., Wolfgang C.L., Schulick R.D., et al. Tumor size and location correlate with behavior of pancreatic serous cystic neoplasms. Am. J. Gastroenterol. 2011;106:1521–1526. doi: 10.1038/ajg.2011.117.
    1. Keane M.G., Dadds H.R., El Sayed G., Luong T.V., Davidson B.R., Fusai G.K., Thorburn D., Pereira S.P. Clinical and radiological features that predict malignant transformation in cystic lesions of the pancreas: A retrospective case note review. Amrc. Open Res. 2020;1:4. doi: 10.12688/amrcopenres.12860.2.
    1. Layne K.A., Dargan P.I., Archer J.R.H., Wood D.M. Gadolinium deposition and the potential for toxicological sequelae—A literature review of issues surrounding gadolinium-based contrast agents. Br. J. Clin. Pharm. 2018;84:2522–2534. doi: 10.1111/bcp.13718.
    1. Keane M.G., Shamali A., Nilsson L.N., Antila A., Millastre Bocos J., Marijinissen Van Zanten M., Verdejo Gil C., Maisonneuve P., Vaalavuo Y., Hoskins T., et al. Risk of malignancy in resected pancreatic mucinous cystic neoplasms. Br. J. Surg. 2018;105:439–446. doi: 10.1002/bjs.10787.
    1. Handrich S.J., Hough D.M., Fletcher J.G., Sarr M.G. The natural history of the incidentally discovered small simple pancreatic cyst: Long-term follow-up and clinical implications. Ajr. Am. J. Roentgenol. 2005;184:20–23. doi: 10.2214/ajr.184.1.01840020.
    1. Cadili A., Bazarrelli A., Garg S., Bailey R. Survival in cystic neoplasms of the pancreas. Can. J. Gastroenterol. 2009;23:537–542. doi: 10.1155/2009/139780.
    1. Yoen H., Kim J.H., Lee D.H., Ahn S.J., Yoon J.H., Han J.K. Fate of small pancreatic cysts (<3 cm) after long-term follow-up: Analysis of significant radiologic characteristics and proposal of follow-up strategies. Eur. Radiol. 2017;27:2591–2599. doi: 10.1007/s00330-016-4589-7.
    1. Khannoussi W., Vullierme M.P., Rebours V., Maire F., Hentic O., Aubert A., Sauvanet A., Dokmak S., Couvelard A., Hammel P., et al. The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2012;12:198–202. doi: 10.1016/j.pan.2012.03.056.
    1. Kamata K., Kitano M., Kudo M., Sakamoto H., Kadosaka K., Miyata T., Imai H., Maekawa K., Chikugo T., Kumano M., et al. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms. Endoscopy. 2014;46:22–29. doi: 10.1055/s-0034-1367539.
    1. Ciprani D., Weniger M., Qadan M., Hank T., Horick N.K., Harrison J.M., Marchegiani G., Andrianello S., Pandharipande P.V., Ferrone C.R., et al. Risk of malignancy in small pancreatic cysts decreases over time. Pancreatology. 2020;20:1213–1217. doi: 10.1016/j.pan.2020.08.003.
    1. Marchegiani G., Andrianello S., Pollini T., Caravati A., Biancotto M., Secchettin E., Bonamini D., Malleo G., Bassi C., Salvia R. “Trivial” Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? Am. J. Gastroenterol. 2019;114:1678–1684. doi: 10.14309/ajg.0000000000000378.
    1. Lee B.S., Nguyen A.K., Tekeste T.F., Chang K., Girgis A., Adeyemo M., Hanna M.S., Yao J.F., Kwok K.K., Giap A.Q., et al. Long-term follow-up of branch-duct intraductal papillary mucinous neoplasms with No change in first 5 Years of diagnosis. Pancreatology. 2021;21:144–154. doi: 10.1016/j.pan.2020.10.040.
    1. Poves I., Burdío F., Morató O., Iglesias M., Radosevic A., Ilzarbe L., Visa L., Grande L. Comparison of Perioperative Outcomes Between Laparoscopic and Open Approach for Pancreatoduodenectomy: The PADULAP Randomized Controlled Trial. Ann. Surg. 2018;268:731–739. doi: 10.1097/SLA.0000000000002893.
    1. van Hilst J., de Rooij T., Bosscha K., Brinkman D.J., van Dieren S., Dijkgraaf M.G., Gerhards M.F., de Hingh I.H., Karsten T.M., Lips D.J., et al. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): A multicentre, patient-blinded, randomised controlled phase 2/3 trial. Lancet Gastroenterol. Hepatol. 2019;4:199–207. doi: 10.1016/S2468-1253(19)30004-4.
    1. de Rooij T., van Hilst J., van Santvoort H., Boerma D., van den Boezem P., Daams F., van Dam R., Dejong C., van Duyn E., Dijkgraaf M., et al. Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD): A Multicenter Patient-blinded Randomized Controlled Trial. Ann. Surg. 2019;269:2–9. doi: 10.1097/SLA.0000000000002979.
    1. Scholten L., van Huijgevoort N.C.M., Bruno M.J., Fernandez-Del Castillo C., Satoi S., Sauvanet A., Wolfgang C., Fockens P., Chari S.T., Del Chiaro M., et al. Surgical management of intraductal papillary mucinous neoplasm with main duct involvement: An international expert survey and case-vignette study. Surgery. 2018;164:17–23. doi: 10.1016/j.surg.2018.01.025.
    1. Lekkerkerker S.J., Besselink M.G., Busch O.R., Verheij J., Engelbrecht M.R., Rauws E.A., Fockens P., van Hooft J.E. Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome. Gastrointest. Endosc. 2017;85:1025–1031. doi: 10.1016/j.gie.2016.09.027.
    1. Singhi A.D., Zeh H.J., Brand R.E., Nikiforova M.N., Chennat J.S., Fasanella K.E., Khalid A., Papachristou G.I., Slivka A., Hogg M., et al. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: A clinicopathologic study of 225 patients with supporting molecular data. Gastrointest. Endosc. 2016;83:1107–1117.e1102. doi: 10.1016/j.gie.2015.12.009.
    1. Ridtitid W., DeWitt J.M., Schmidt C.M., Roch A., Stuart J.S., Sherman S., Al-Haddad M.A. Management of branch-duct intraductal papillary mucinous neoplasms: A large single-center study to assess predictors of malignancy and long-term outcomes. Gastrointest. Endosc. 2016;84:436–445. doi: 10.1016/j.gie.2016.02.008.
    1. Lennon A.M., Manos L.L., Hruban R.H., Ali S.Z., Fishman E.K., Kamel I.R., Raman S.P., Zaheer A., Hutfless S., Salamone A., et al. Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: A single-center cohort study. Ann. Surg. Oncol. 2014;21:3668–3674. doi: 10.1245/s10434-014-3739-x.
    1. He J., Cameron J.L., Ahuja N., Makary M.A., Hirose K., Choti M.A., Schulick R.D., Hruban R.H., Pawlik T.M., Wolfgang C.L. Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J. Am. Coll. Surg. 2013;216:657–665. doi: 10.1016/j.jamcollsurg.2012.12.026.
    1. Pflüger M.J., Griffin J.F., Hackeng W.M., Kawamoto S., Yu J., Chianchiano P., Shin E., Lionheart G., Tsai H.L., Wang H., et al. The Impact of Clinical and Pathological Features on Intraductal Papillary Mucinous Neoplasm Recurrence After Surgical Resection: Long-Term Follow-Up Analysis. Ann. Surg. 2020 doi: 10.1097/SLA.0000000000004427.
    1. Balaban E.P., Mangu P.B., Khorana A.A., Shah M.A., Mukherjee S., Crane C.H., Javle M.M., Eads J.R., Allen P., Ko A.H., et al. Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2016;34:2654–2668. doi: 10.1200/JCO.2016.67.5561.
    1. Valsangkar N.P., Morales-Oyarvide V., Thayer S.P., Ferrone C.R., Wargo J.A., Warshaw A.L., Fernandez-del Castillo C. 851 resected cystic tumors of the pancreas: A 33-year experience at the Massachusetts General Hospital. Surgery. 2012;152:S4–S12. doi: 10.1016/j.surg.2012.05.033.
    1. Sahora K., Mino-Kenudson M., Brugge W., Thayer S.P., Ferrone C.R., Sahani D., Pitman M.B., Warshaw A.L., Lillemoe K.D., Fernandez-del Castillo C.F. Branch duct intraductal papillary mucinous neoplasms: Does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann. Surg. 2013;258:466–475. doi: 10.1097/SLA.0b013e3182a18f48.
    1. Crippa S., Bassi C., Salvia R., Falconi M., Butturini G., Pederzoli P. Enucleation of pancreatic neoplasms. Br. J. Surg. 2007;94:1254–1259. doi: 10.1002/bjs.5833.
    1. Kiely J.M., Nakeeb A., Komorowski R.A., Wilson S.D., Pitt H.A. Cystic pancreatic neoplasms: Enucleate or resect? J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract. 2003;7:890–897. doi: 10.1007/s11605-003-0035-7.
    1. Gan S.I., Thompson C.C., Lauwers G.Y., Bounds B.C., Brugge W.R. Ethanol lavage of pancreatic cystic lesions: Initial pilot study. Gastrointest. Endosc. 2005;61:746–752. doi: 10.1016/S0016-5107(05)00320-2.
    1. Oh H.C., Seo D.W., Lee T.Y., Kim J.Y., Lee S.S., Lee S.K., Kim M.H. New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection. Gastrointest. Endosc. 2008;67:636–642. doi: 10.1016/j.gie.2007.09.038.
    1. Oh H.C., Seo D.W., Kim S.C., Yu E., Kim K., Moon S.H., Park do H., Lee S.S., Lee S.K., Kim M.H. Septated cystic tumors of the pancreas: Is it possible to treat them by endoscopic ultrasonography-guided intervention? Scand. J. Gastroenterol. 2009;44:242–247. doi: 10.1080/00365520802495537.
    1. DeWitt J., McGreevy K., Schmidt C.M., Brugge W.R. EUS-guided ethanol versus saline solution lavage for pancreatic cysts: A randomized, double-blind study. Gastrointest. Endosc. 2009;70:710–723. doi: 10.1016/j.gie.2009.03.1173.
    1. Oh H.C., Seo D.W., Song T.J., Moon S.H., Park do H., Soo Lee S., Lee S.K., Kim M.H., Kim J. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology. 2011;140:172–179. doi: 10.1053/j.gastro.2010.10.001.
    1. DeWitt J.M., Al-Haddad M., Sherman S., LeBlanc J., Schmidt C.M., Sandrasegaran K., Finkelstein S.D. Alterations in cyst fluid genetics following endoscopic ultrasound-guided pancreatic cyst ablation with ethanol and paclitaxel. Endoscopy. 2014;46:457–464. doi: 10.1055/s-0034-1365496.
    1. Moyer M.T., Dye C.E., Sharzehi S., Ancrile B., Mathew A., McGarrity T.J., Gusani N., Yee N., Wong J., Levenick J., et al. Is alcohol required for effective pancreatic cyst ablation? The prospective randomized CHARM trial pilot study. Endosc. Int. Open. 2016;4:E603–E607. doi: 10.1055/s-0042-105431.
    1. Kim K.H., McGreevy K., La Fortune K., Cramer H., DeWitt J. Sonographic and cyst fluid cytologic changes after EUS-guided pancreatic cyst ablation. Gastrointest. Endosc. 2017;85:1233–1242. doi: 10.1016/j.gie.2016.09.011.
    1. Moyer M.T., Sharzehi S., Mathew A., Levenick J.M., Headlee B.D., Blandford J.T., Heisey H.D., Birkholz J.H., Ancrile B.B., Maranki J.L., et al. The Safety and Efficacy of an Alcohol-Free Pancreatic Cyst Ablation Protocol. Gastroenterology. 2017;153:1295–1303. doi: 10.1053/j.gastro.2017.08.009.
    1. Attila T., Adsay V., Faigel D.O. The efficacy and safety of endoscopic ultrasound-guided ablation of pancreatic cysts with alcohol and paclitaxel: A systematic review. Eur. J. Gastroenterol. Hepatol. 2019;31:1–9. doi: 10.1097/MEG.0000000000001297.
    1. Choi J.H., Seo D.W., Song T.J., Park D.H., Lee S.S., Lee S.K., Kim M.H. Long-term outcomes after endoscopic ultrasound-guided ablation of pancreatic cysts. Endoscopy. 2017;49:866–873. doi: 10.1055/s-0043-110030.
    1. Barthet M., Giovannini M., Lesavre N., Boustiere C., Napoleon B., Koch S., Gasmi M., Vanbiervliet G., Gonzalez J.M. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: A prospective multicenter study. Endoscopy. 2019;51:836–842. doi: 10.1055/a-0824-7067.
    1. Pai M., Habib N., Senturk H., Lakhtakia S., Reddy N., Cicinnati V.R., Kaba I., Beckebaum S., Drymousis P., Kahaleh M., et al. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World J. Gastrointest. Surg. 2015;7:52–59. doi: 10.4240/wjgs.v7.i4.52.
    1. Teoh A.Y., Seo D.W., Brugge W., Dewitt J., Kongkam P., Linghu E., Moyer M.T., Ryu J.K., Ho K.Y. Position statement on EUS-guided ablation of pancreatic cystic neoplasms from an international expert panel. Endosc. Int. Open. 2019;7:E1064–E1077. doi: 10.1055/a-0959-5870.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera